Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

The U.S. already has the world's highest prescription drug prices, and these annual increases will push up costs for COVID and cancer treatment, among many medications.

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...

The caps are mandated by the Inflation Reduction Act. No Medicare patient will pay more than $2,000 out of pocket for ...

Several major pharmaceutical companies, including Pfizer, Bristol Myers Squibb and Sanofi, are set to raise prices on more than 250 branded medications in the U.S. starting Jan. 1, 2025, according to ...

Going into the new year, seniors who take prescription drugs and receive Medicare benefits are likely to shell out less for ...

Parliamentary panel slams drug pricing regulator for hike on 11 drugs used for treating conditions such as asthma, glaucoma, ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Pharmacy-benefit managers are facing intense pressure in Washington.

India's drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), has come under scrutiny from the parliamentary standing committee on chemicals and fertilisers for permitting a 50 ...

India's parliamentary committee criticized the drug pricing regulator for approving a 50% price increase on 11 drug ...

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for ...